New York 2025-2026 Regular Session

New York Assembly Bill A03127

Introduced
1/23/25  
Refer
1/23/25  

Caption

Allows for treatment costing less than $1,500 to be done without prior approval, and more clearly defines the list of "pre-authorized procedures" as a floor on treatment as opposed to its current status as a ceiling; allows non-network providers of testing to be compensated at the provider network rate negotiated by the carrier.

Summary

Bill A03127 amends the workers' compensation law to enhance access to medical treatment for injured workers. It allows for treatments costing less than $1,500 to be administered without prior approval from employers or insurance carriers. Additionally, it clarifies that the list of pre-authorized procedures is intended to serve as a minimum standard for treatment, rather than a limit, thereby enabling more flexibility in the types of treatments that can be pursued by injured workers. The bill also stipulates that diagnostic tests costing more than $1,500 performed by non-network providers must be compensated at the negotiated network rate, ensuring that injured workers have access to necessary diagnostic services without financial penalty for using out-of-network providers.

Impact

The bill significantly impacts the workers' compensation framework in New York by streamlining the authorization process for medical treatments, which could lead to quicker access to necessary care for injured workers. By allowing treatments under $1,500 to proceed without prior approval, it reduces administrative delays and potential barriers to care. The requirement for non-network providers to be compensated at the negotiated rate also ensures that injured workers are not financially disadvantaged when seeking necessary diagnostic tests, promoting fairer treatment access across different healthcare providers.

Sentiment

The general sentiment surrounding Bill A03127 appears to be supportive among advocates for injured workers, who argue that it will improve access to timely medical care and reduce bureaucratic hurdles. However, there may be concerns from employers and insurance carriers regarding the potential increase in costs associated with the expanded access to treatments and the requirement for payment to non-network providers at negotiated rates.

Contention

Notable points of contention include the potential financial implications for employers and insurance carriers, who may oppose the bill due to concerns about increased treatment costs and the broader implications of allowing treatments without prior approval. Proponents argue that the benefits of timely access to care for injured workers outweigh these concerns, while opponents fear that it could lead to unnecessary treatments and higher overall costs in the workers' compensation system.

Companion Bills

NY S06217

Same As Allows for treatment costing less than $1,500 to be done without prior approval, and more clearly defines the list of "pre-authorized procedures" as a floor on treatment as opposed to its current status as a ceiling; allows non-network providers of testing to be compensated at the provider network rate negotiated by the carrier.

Previously Filed As

NY S06217

Allows for treatment costing less than $1,500 to be done without prior approval, and more clearly defines the list of "pre-authorized procedures" as a floor on treatment as opposed to its current status as a ceiling; allows non-network providers of testing to be compensated at the provider network rate negotiated by the carrier.

NY S00306

Provides that a non-network pharmacy that provides causally related medications to a claimant shall be entitled to payment at the network rate negotiated between the carrier and the pharmacy network if the carrier's network provides mail order service or is located within a reasonable distance from the claimant; reduces costs of treatment by requiring out of network providers accept payment at the carrier's negotiated network rate, while at the same time allowing injured workers to obtain treatment in a timely manner by providing for payment to the provider when they do not obtain the treatment within the network; provides that any special diagnostic tests, x-ray examinations, magnetic resonance imaging or other radiological examinations or tests costing more than one thousand dollars performed by a provider who is not a member of the carrier's, self insured's or state insurance fund's diagnostic networks, shall be entitled to payment at the negotiated network rate.

NY S00304

Simplifies the procedure by which injured workers obtain treatment for injuries covered by the workers' compensation law; provides that the list of pre-authorized procedures is to be used only as a list of treatment that does not require insurance carrier approval.

NY A06205

Simplifies the procedure by which injured workers obtain treatment for injuries covered by the workers' compensation law; provides that the list of pre-authorized procedures is to be used only as a list of treatment that does not require insurance carrier approval.

NY S07919

Allows dental provider networks, certain health and hospital service corporations, and health care plans to enter into a third-party network contract to provide access to care services and discounted rates of a provider under a provider network contract.

LA HR338

Requests the Department of Insurance to study the impact on automobile insurance rates when bodily injury claimants submit medical treatment claims for accident-related injuries to out-of-network providers rather than in-network providers

LA HR260

INSURANCE: Requests the Department of Insurance to study the impact on automobile insurance rates when bodily injury claimants submit medical treatment claims for accident-related injuries to out-of-network providers rather than in-network providers

OR SB822

Relating to provider networks.

NJ A1509

Establishes arbitration and notification process for health insurance carriers and provider networks when dispute arises over maintaining providers as in-network.

NY S10232

Relates to not requiring a prior authorization determination for certain categories of cancer treatments based on National Comprehensive Cancer Network Guidelines.

Similar Bills

No similar bills found.